Despite Washington's reputation for healthcare innovation, accessing GLP-1 treatment in Poulsbo can still mean navigating insurance hurdles. Wegovy® is the FDA-approved Injectable pen Semaglutide product manufactured by Novo Nordisk. Weight Method offers a separate option: licensed Washington providers evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program starts at $199/month, including the provider evaluation, the medication, ongoing care, and shipping to your Poulsbo address.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Poulsbo is already seeing results
GLP-1 weight-loss treatment available to eligible patients in Poulsbo, WA. Weight Method offers compounded semaglutide, prescribed by licensed providers, from $199/month with virtual consultations and direct-to-door shipping.
For many people in Poulsbo, diet and exercise alone have not produced lasting results — and that is not a failure of willpower. Semaglutide addresses hormonal drivers involved in body weight regulation. Wegovy® is the FDA-approved Injectable pen Semaglutide product by Novo Nordisk, approved in 2021 for Chronic weight management. Weight Method offers a separate telehealth program: licensed providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The program is priced at $199/month, including the evaluation, the medication, ongoing care, and home delivery to Poulsbo.
Suburban life around Poulsbo comes with its own weight management challenges — car-dependent commutes, limited walkability, and the convenience of drive-throughs. Semaglutide therapy addresses biology involved in weight regulation by reducing hunger signals, so Poulsbo area residents can break patterns that willpower alone cannot fix. Weight Method prescribes compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy, at $199/month, delivered to your door. Compounded Semaglutide is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Washington and start Wegovy from $199/month.
Get Started NowFree consultation. No commitment.